Business

Further sales expansion in Asia

Further sales expansion in Asia.

articleOptibiotix Health PlcJuly 6, 20215/company/optibiotix-health-plc/news/further-sales-expansion-in-asia
Further sales expansion in Asia

About this update from Optibiotix Health Plc

[{"type":"text","content":"\n \n \n \n RNS Number : 2351E\n OptiBiotix Health PLC\n 06 July 2021\n  \n \n \n OptiBiotix Health plc\n \n \n (\"\n \n OptiBiotix\" or the \"Company\")\n \n  \n Further sales expansion in Asia\n New Exclusive Distribution deal for CholBiome® in South Korea\n  \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare,announces that its wholly-owned subsidiary, ProBiotix Health Ltd. (\"ProBiotix\"), has entered a exclusive disbution deal with INSCOBEE INC (\"Inscobee\") for CholBiome® in the Republic of Korea.\n  \n \n Inscobee was established in 1970 and is listed on Korea's major stock market KOSPI since 1985.  Its business activities consist of four fast growing business fields: the Smart grid, Mobile Virtual Network Operation, Cosmetics, and Bio-Tech, which includes its pharmaceutical, neutraceuticals, and supplement products with distribution in domestic and overseas markets.  Inscobee's group turover was 57.8 billion Korean Won (USD 52.2m) last year and they are curently focused on expanding the health supplement area of their business.\n \n \n  \n \n \n Inscobee sell and promote nutraceuticals through hospitals and a consumer distribution base through Korean off-line channels such as Holland & Barrett stores, hypermarkets, home-shopping, and e-commerce channels including on-line malls, open markets, influencer markets and live commerce markets.\n \n \n  \n \n \n This agreement with Inscobee is another milestone in a series of deals which ProBiotix have entered into within Asia which help build LP LDL® and CholBiome's reputation and brand awareness in the region and open up the potentail for cross boarder e-commerce trading in China. ProBiotix Health has substantial momentum in the region, according to a recent article published in Nutraingredient Asia: \n Probiotics and CVD: OptiBiotix extends CholBiome range to APAC as blood pressure and cholesterol concerns rise (nutraingredients-asia.com)\n .\n \n  \n \n \n Mr. Mikkel Hvid-Hansen, Commercial Director of ProBiotix Health commened:\n \n \"Incobee is the ideal partner in the fast moving, highly dynamic and competitive South Korean health food markets where co...

More updates from Optibiotix Health Plc